Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0348-2023

Drug recall · March 1, 2023

Warfarin Sodium Tablets recall

Why: Failed Impurities/Degradation Specifications

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01

Lots / codes

Batch #: NB101596, Exp. 04/30/2023

Quantity
12,216 bottles (100 count each)
Company
Rising Pharmaceuticals, East Brunswick, NJ
Distribution
Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.
Initiated
February 15, 2023 · Voluntary: Firm initiated
Classified
February 23, 2023
Reported
March 1, 2023
Ended
June 14, 2024
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Warfarin

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.